ALKBH5 and glioblastoma: ALKBH5 is necessary for GSC self-renewal, and increased ALKBH5 expression typically indicates a poor prognosis in patients with glioblastoma (GBM), whereas ALKBH5 deletion can inhibit GSC proliferation and tumorigenesis [84].